_________
false
ביוליין אר אקס בע"מ
2
379
BIOLINE RX LTD
Corporation no:
513398750
9253
Israel Securities Authority
Tel Aviv Stock Exchange
C001
(
Public
)
Reported via MAGNA:
12/11/2019
www.isa.gov.il
www.tase.co.il
Reference:
2019-02-110365
Time of broadcast:
12:50
12:45:48
Report of Periodic or Interim Report
Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
BioLineRx completes report of third quarter 2019 financial results
6-K_Q319_results_isa.pdf
Link to filing on foreign stock exchange (optional):
_________
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2019-02-109981
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
29/10/2019
Address:
HaMa'ayan
2
,
Modi'in
7177871
,
Israel
Tel:
08-6429100
,
Fax:
08-6429101
E-mail address:
info@BioLineRx.com
Company site:
www.biolinerx.com
Previous names of reporting entity:
Name of the Signatory:
Kotler Norman Harold
Position of Signatory in the reporting corporation:
General Counsel & Company Secretary
Name of Employer Company:
Address:
HaMa'ayan
2
,
Modi'in
7177871
Telephone:
08-6429100
Facsimile:
08-6429101
E-mail:
normank@biolinerx.com
1
Israel